Article
Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.
JAMA oncology - 1 Sept 2017
Neidhardt Guido, Hauke Jan, Ramser Juliane, Groß Eva, Gehrig Andrea, Müller Clemens R, Kahlert Anne-Karin, Hackmann Karl, Honisch Ellen, Niederacher Dieter, Heilmann-Heimbach Stefanie, Franke André, Lieb Wolfgang, Thiele Holger, Altmüller Janine, Nürnberg Peter, Klaschik Kristina, Ernst Corinna, Ditsch Nina, Jessen Frank, Ramirez Alfredo, Wappenschmidt Barbara, Engel Christoph, Rhiem Kerstin, Meindl Alfons, Schmutzler Rita K, Hahnen Eric
Abstract excerpt
IMPORTANCE: Germline mutations in established moderately or highly penetrant risk genes for breast cancer (BC) and/or ovarian cancer (OC), including BRCA1 and BRCA2, explain fewer than half of all familial BC and/or OC cases. Based on the genotyping of 2 loss-of-function (LoF) variants c.5101C>T (p.GIn1701Ter [rs147021911]) and c.5791C>T (p.Arg1931Ter [rs144567652]), the FANCM gene has been suggested as a novel...
Read the complete abstract on PubMed